Lachlan Oldfield
Impact in
- Pharmacology top 10%
- Cannabis and Cannabinoid Research
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmaceutical Economics and Policy 3
-
- Cannabis and Cannabinoid Research 2
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Rebekah Moles (3 shared papers)Jonathan Penm (3 shared papers)Betty Chaar (1 shared paper)Lyndsey L. Anderson (2 shared papers)Jonathon C. Arnold (2 shared papers)Peter T. Doohan (2 shared papers)Richard C. Kevin (1 shared paper)Maximus Berger (1 shared paper)
In The Last Decade
Lachlan Oldfield
6 papers receiving 241 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 80
- Business and International Management 7
- Economics and Econometrics 79
- Geriatrics and Gerontology 9
- Pharmacology 23
Countries citing papers authored by Lachlan Oldfield
This map shows the geographic impact of Lachlan Oldfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lachlan Oldfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lachlan Oldfield more than expected).
Fields of papers citing papers by Lachlan Oldfield
This network shows the impact of papers produced by Lachlan Oldfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lachlan Oldfield. The network helps show where Lachlan Oldfield may publish in the future.
Co-authors
The 16 scholars most cited alongside Lachlan Oldfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 133 | |
| 2 | 2021 | 67 | |
| 3 | 2021 | 34 | |
| 4 | 2024 | 10 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 2 |
About Lachlan Oldfield
Lachlan Oldfield is a scholar working on Economics and Econometrics, Pharmacology, Pharmacology, Psychiatry and Mental health and Infectious Diseases, having authored 6 papers that have together received 248 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (3 papers), Cannabis and Cannabinoid Research (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Pharmacology (80 citations), Business and International Management (7 citations), Economics and Econometrics (79 citations), Geriatrics and Gerontology (9 citations) and Pharmacology (23 citations). Lachlan Oldfield has collaborated with scholars based in Australia, Vietnam and Indonesia. Frequent co-authors include Rebekah Moles, Jonathan Penm, Betty Chaar, Lyndsey L. Anderson, Jonathon C. Arnold, Peter T. Doohan, Richard C. Kevin, Maximus Berger, Iain S. McGregor and G. Paul Amminger. Their work appears in journals such as Journal of Clinical Psychopharmacology, The AAPS Journal, The Lancet Global Health, The Lancet Regional Health - Western Pacific and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.